EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Dried blood spot LC-MS/MS quantification of voclosporin in renal transplant recipients using volumetric dried blood spot sampling

E Metscher, S Meziyerh, E J Arends, Y K O Teng, A P J de Vries, J J Swen, D J A R Moes

Journal of Pharmaceutical and Biomedical Analysis · 2025

DOI: 10.1016/j.jpba.2024.116647 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2025. Verfasst von E Metscher und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands; Leiden Network for Personalized Medicine, …. Hauptthemen laut MEDLINE: Dried Blood Spot Testing, Cyclosporine, Kidney Transplantation, Immunosuppressive Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Voclosporin is a potent immunosuppressive agent currently approved for treating active lupus nephritis. Based on its potential antiviral activity, it has also been investigated as immunosuppressive agent in an investigator-initiated study in SARS-CoV2 positive kidney transplant recipients. As with many immunosuppressive agents, optimizing dosing regimens to achieve therapeutic efficacy while minimizing toxicity remains a critical challenge in clinical practice. To prevent organ rejection as well as infections, the prescribed immunosuppression needs to be well balanced. Dried blood spot (DBS) sampling has enabled development of remote voclosporin therapeutic drug monitoring. Here, we report on the development and analytical validation of a liquid chromatography tandem mass spectrometry (LC-MS/MS) assay for quantification of voclosporin in dried blood spots. Method development was based on previously developed assays for the quantification of tacrolimus, everolimus, sirolimus, cyclosporin, mycophenolic acid, creatinine and iohexol in DBS and voclosporin in whole blood using LC-MS/MS. HemaXis™ volumetric blood spot devices were used for sample collection. The sample purification was based on the extraction of voclosporin from the DBS samples. Stable isotopically labeled voclosporin-D4 was used as an internal standard prior to sample purification. Bland Altman and Passing bablok analysis were performed for cross validation between whole blood and DBS samples. The method was successfully validated following the current ICH M10 guidelines. The dynamic range for the analyte was 10-600 µg/L with an excellent mean coefficient of correlation of 0.9978. The within run and between run precision and accuracy were both within the acceptance criteria. The cross-validation against the whole blood method shows that the quantified voclosporin results are promising. This developed dried blood spot LC-MS/MS method was successfully validated and provides an easy, efficient workflow for therapeutic drug monitoring in kidney transplant patients or remote pharmacokinetic studies in lupus nephritis patients treated with voclosporin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dried Blood Spot TestingCyclosporineKidney TransplantationImmunosuppressive AgentsHumansTandem Mass SpectrometryDrug MonitoringChromatography, LiquidReproducibility of ResultsTransplant RecipientsLimit of DetectionLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

Dried blood spotsLC-MS/MSMicrosamplingTherapeutic Drug MonitoringVoclosporin

Substanzen

CyclosporineImmunosuppressive Agentsvoclosporin

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands; Leiden Network for Personalized Medicine, Leiden, the Netherlands.
  • Department of Internal Medicine, Division of Nephrology, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Internal Medicine, Division of Nephrology, Leiden University Medical Center, Leiden, the Netherlands; Leiden Transplant Center, Leiden, the Netherlands.
  • Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands; Leiden Network for Personalized Medicine, Leiden, the Netherlands. Electronic address: d.j.a.r.moes@lumc.nl.

Zitieren

APA

Metscher, E., Meziyerh, S., Arends, E. J., Teng, Y. K. O., de Vries, A. P. J., Swen, J. J., & Moes, D. J. A. R. (2025). Dried blood spot LC-MS/MS quantification of voclosporin in renal transplant recipients using volumetric dried blood spot sampling. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2024.116647

Vancouver

Metscher E, Meziyerh S, Arends EJ, Teng YKO, de Vries APJ, Swen JJ, et al. Dried blood spot LC-MS/MS quantification of voclosporin in renal transplant recipients using volumetric dried blood spot sampling. Journal of Pharmaceutical and Biomedical Analysis. 2025. doi:10.1016/j.jpba.2024.116647

BibTeX
@article{Metscher2025,
  author = {Metscher, E and Meziyerh, S and Arends, E J and Teng, Y K O and de Vries, A P J and Swen, J J and Moes, D J A R},
  title = {Dried blood spot LC-MS/MS quantification of voclosporin in renal transplant recipients using volumetric dried blood spot sampling},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2025},
  doi = {10.1016/j.jpba.2024.116647}
}
Kostenlos starten →